Author:
Pearson Andrew D.J.,Scobie Nicole,Norga Koenraad,Ligas Franca,Chiodin Davy,Burke Amos,Minard-Colin Veronique,Adamson Peter,Marshall Lynley V.,Balakumaran Arun,Benettaib Bouchra,Bhargava Pankaj,Bollard Catherine M.,Bolotin Ellen,Bomken Simon,Buechner Jochen,Burkhardt Birgit,Caron Hubert,Copland Christopher,Demolis Pierre,Egorov Anton,Farhan Mahdi,Zugmaier Gerhard,Gross Thomas,Horton-Taylor Danielle,Klapper Wolfram,Lesa Giovanni,Marcus Robert,Miles Rodney R.,Nottage Kerri,Pacaud Lida,Ricafort Rosanna,Schrappe Martin,Sterba Jaroslav,Vezan Remus,Weiner Susan,Kim Su Young,Reaman Gregory,Vassal Gilles
Reference40 articles.
1. New drugs for children and adolescents with cancer: the need for novel development pathways;Vassal;Lancet Oncol,2013
2. Implementation of mechanism of action biology-driven early drug development for children with cancer;Pearson;Eur J Cancer,2016
3. https://www.ema.europa.eu/documents/other/european-medicines-agency-decision-cw-0001-2015-23-july-2015-class-waivers-accordance-regulation-ec_en.pdf.
4. https://www.congress.gov/bill/115th-congress/house-bill/2430/text?q=%7B%22search%22%3A%5B%22hr+2430%22%5D%7D&r=1#HA66BE74406C94DCDB3792C9FF6A1509C [Accessed 22 August 2018].
5. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2017/06/WC500228940.pdf [Accessed 22 August 2018].